| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |